Abstract
The inhibitory and bactericidal activities of a novel cyclic peptide antibiotic, LY146032, and vancomycin against oxacillin-susceptible and oxacillin-resistant staphylococci were compared. The MICs for 90% of strains were two- to fourfold higher for vancomycin than for LY146032. MBC/MIC ratios for all strains were less than or equal to 2. In killing rate studies with four strains of staphylococci, there was no detectable growth in the presence of 4X the MIC of either LY146032 or vancomycin after 24 h of incubation.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference3 articles.
1. National Committee for Clinical Laboratory Standards. 1984. Performance standards for antimicrobial disk susceptibility tests 3rd ed. M2-M3. National Committee for Clinical Laboratory Standards Villanova Pa.
2. National Committee for Clinical Laboratory Standards. 1985. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically M7-A. National Committee for Clinical Laboratory Standards Villanova Pa.
3. MBCs for Staphylococcus aureus as determined by macrodilution and microdilution techniques;Shanholtzer C. J.;Antimicrob. Agents Chemother.,1984
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献